chr21-46001222-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000498614.5(COL6A1):n.26C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.036 in 1,595,018 control chromosomes in the GnomAD database, including 1,286 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.026   (  75   hom.,  cov: 34) 
 Exomes 𝑓:  0.037   (  1211   hom.  ) 
Consequence
 COL6A1
ENST00000498614.5 non_coding_transcript_exon
ENST00000498614.5 non_coding_transcript_exon
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.36  
Publications
3 publications found 
Genes affected
 COL6A1  (HGNC:2211):  (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008] 
COL6A1 Gene-Disease associations (from GenCC):
- collagen 6-related myopathyInheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
 - Bethlem myopathy 1AInheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
 - Ullrich congenital muscular dystrophy 1AInheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 - Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77). 
BP6
Variant 21-46001222-C-T is Benign according to our data. Variant chr21-46001222-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93836.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0262 (3993/152282) while in subpopulation NFE AF = 0.0441 (2996/67974). AF 95% confidence interval is 0.0428. There are 75 homozygotes in GnomAd4. There are 1794 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 75 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| COL6A1 | NM_001848.3  | c.1823-31C>T | intron_variant | Intron 29 of 34 | ENST00000361866.8 | NP_001839.2 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0262  AC: 3994AN: 152164Hom.:  75  Cov.: 34 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
3994
AN: 
152164
Hom.: 
Cov.: 
34
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0266  AC: 6263AN: 235740 AF XY:  0.0269   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
6263
AN: 
235740
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0370  AC: 53417AN: 1442736Hom.:  1211  Cov.: 32 AF XY:  0.0363  AC XY: 26050AN XY: 716954 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
53417
AN: 
1442736
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
26050
AN XY: 
716954
show subpopulations 
African (AFR) 
 AF: 
AC: 
184
AN: 
33342
American (AMR) 
 AF: 
AC: 
576
AN: 
44616
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
429
AN: 
26074
East Asian (EAS) 
 AF: 
AC: 
4
AN: 
39526
South Asian (SAS) 
 AF: 
AC: 
938
AN: 
86142
European-Finnish (FIN) 
 AF: 
AC: 
1471
AN: 
39844
Middle Eastern (MID) 
 AF: 
AC: 
26
AN: 
5740
European-Non Finnish (NFE) 
 AF: 
AC: 
48049
AN: 
1107510
Other (OTH) 
 AF: 
AC: 
1740
AN: 
59942
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.468 
Heterozygous variant carriers
 0 
 2416 
 4832 
 7249 
 9665 
 12081 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 1754 
 3508 
 5262 
 7016 
 8770 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0262  AC: 3993AN: 152282Hom.:  75  Cov.: 34 AF XY:  0.0241  AC XY: 1794AN XY: 74460 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
3993
AN: 
152282
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
1794
AN XY: 
74460
show subpopulations 
African (AFR) 
 AF: 
AC: 
275
AN: 
41574
American (AMR) 
 AF: 
AC: 
204
AN: 
15310
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
48
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5176
South Asian (SAS) 
 AF: 
AC: 
40
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
321
AN: 
10626
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
2996
AN: 
67974
Other (OTH) 
 AF: 
AC: 
53
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.494 
Heterozygous variant carriers
 0 
 213 
 426 
 639 
 852 
 1065 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 46 
 92 
 138 
 184 
 230 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
22
AN: 
3476
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:2 
Sep 05, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Jun 26, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.